Manejo de los pacientes con diabetes en la época de COVID-19: Recomendaciones prácticas

The first registers of atypical pneumonia were reported in China by the end of December 2019. The disease was rapidly disseminated in the entire world. The spectrum of the clinical manifestations is large going from individuals without any symptoms to those who develop multisystem disease and death. It has been demonstrated that hypertension and diabetes are more frequent in people with COVID-19 and the presence of diabetes is associated with an increased risk of more severe disease and higher mortality. In the present article, we review the possible mechanism why the diabetes patients have an increased risk of mortality by COVID-19 and recommend preventive actions that must be implemented in the general population and particularly in individuals with diabetes.